Atlas Trials

Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer

Clinical trial NCT02486198 · COMPLETED

Trial details

NCT number
NCT02486198
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neurotoxicity
Start date
2015-05-05
Primary completion
2018-01-11
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.